Testimonials

"Our experience with the ThruPLEX library prep has been extremely positive. Both at Rubicon and in our hands it has proven able to generate high quality, diverse libraries from 10x less input than other kits we have used. For us this technology truly enables the study of samples that simply weren't possible before adopting it." - Henry Long, Ph.D., Associate Director, Center for Functional Cancer Epigenetics Dana-Farber Cancer Institute

"ThruPLEX-FD outperformed standard NGS library preparation methods both in terms of library complexity (i.e., proportion of unique sequences) and GC-representation, particularly for precious sub-nanogram inputs." -Next-Gen Sequencing lab, University of Washington

"After testing the ThruPLEX-FD kit, we were truly convinced by its ease of use but, most importantly, by the quality of the data generated. The ThruPLEX kit effectively allows you to amplify limiting amounts of DNA and the ChIP-seq profiles obtained with as low as 10 pg starting material were really accurate in terms of sensitivity and reproducibility. Having access to that kind of technology becomes of particular importance in the epigenetic field where more and more people want to perform microChIP experiments from rare cells." -R&D Epigenetics group, Diagenode

"So far, I have made NGS libraries from 5 different kits from 4 sources and ThruPLEX is the easiest/simplest protocol to follow, workflow was smooth, and there was a minimal number of reagents to keep track of. I am impressed and amazed at the "complexity" of the strategy behind the kit. I have done multiplexing of amplicons in PCR but haven't heard of multiplexing enzymes/reactions all in one tube without purification in between, until now" -T.M., Myriad Genetics, Inc.

“Rubicon’s TransPLEX RNA amplification technology for FFPE samples was a standout in our evaluation of the available options for use with our Symphony products for the diagnosis and management of breast cancer,” - David Macdonald, CEO of Agendia.

“TransPLEX offers product performance and workflow advantages, producing superior results while taking less time. In line with our commitment to ongoing innovation and product excellence, we look forward to incorporating this superior technology into our ongoing diagnostic operations.” -David Macdonald, CEO of Agendia

“SurePlex [PicoPLEX] represents a major step forward in amplification technology…we selected SurePLEX due to its rapid protocol, highly representative amplification, and low allele dropout when compared to other amplification methods” –Nick Haan, founder and CEO of BlueGnome

“The EasyAmp technology increases the sensitivity and reproducibility of any type of single-cell analysis and delivers faster, simpler, more producible results” –Alessandro Borsatti, Global Business director, PerkinElmer, Inc.

“We use the PicoPlex WGA technology because it reproducibly amplifies a large percentage of the genome every time, making the data sets easy to anticipate and accommodate. We especially like the predictability of this product when examining many alleles from single haploid and diploid cells.” –Mark Hughes, Chief Scientific Officer of Genesis Genetics Institute

“Using PicoPLEX™ we can combine highly accurate chromosome screening, using array-CGH or SNP microarrays, with diagnosis of single gene disorders via PCR amplification plus mutation detection or again using SNP array” -Dagan Wells, University of Oxford

“PicoPLEX™ is a critical and reliable component of our stem cell research at single cell level". -"Senior scientist, Jonas Frisen's laboratory, Karolinska Institute Stockholm, Sweden.